The Skin Diary, the anti-ageing skincare solutions provider, has acquired CGSkin Limited, a spinout born from the collaborative efforts of The University of Manchester and renowned dermatologists, Dr Tamara Griffiths and Professor Chris Griffiths.
This strategic partnership marks a significant milestone for the brands in their pursuit of dermatological research advancement and skincare innovation. The Skin Diary will be launching the first of the CGSkin products, Night Repair Therapy on 25 October 2024. Night Repair Therapy is a true innovation designed to regenerate and rebuild collagen and elastin in prematurely aged skin without irritation.
Founded in 2023 by leading researchers in skin ageing, The Skin Diary is modernising skincare through its innovative product Chapters. The Skin Diary offers prescription-grade skincare routines that leverage skin cycling to deliver optimal outcomes to patients while minimising irritation.
CGSkin, a University of Manchester spinout, is built on a decade of rigorous research and collaboration between the University and eminent dermatologists Dr Tamara Griffiths and Professor Chris Griffiths. Their suite of anti-ageing products has undergone exhaustive testing to the highest standards, including unprecedented human skin biopsy studies.
With the acquisition of CGSkin, The Skin Diary is set apart from other skincare brands due to its academic lineage and the expertise of its founders. Professor Chris Griffiths is a distinguished figure in skin research; his seminal research on topical retinoids has made a huge impact on the field of skin ageing. Dr Tamara Griffiths brings invaluable aesthetic science expertise to the partnership.
Only 8.6% of the skincare market is dispensed by physicians, and Chapters provides patients with a fully personalised profile with continuous access to dermatologists through their Skin Diary portal.
Catherine Headley, CEO of the University of Manchester Innovation Factory said: “This acquisition exemplifies the spirit of innovation, something that is part of the foundation of The University of Manchester. Impact like this doesn’t happen overnight; it can be many years in the making. Everyone at the Innovation Factory is proud to see Professor and Dr Griffiths and their research welcomed into The Skin Diary family and we are honoured to have been able to support them on their journey.”
“The acquisition of CGSkin by The Skin Diary is a testament to our dedication to providing patients with the most effective and innovative skincare solutions,” said Dr Clare Kiely, Chief Medical Officer of the Skin Diary. “We are excited to integrate CGSkin’s ground-breaking products into our portfolio, furthering our mission to empower individuals with access to advanced anti-ageing treatments.”
Skincare is the leading sector in a thriving beauty market, accounting for 40% in 2023. Growing awareness of physician-dispensed cosmeceuticals means there is increasing demand for prescription-grade skincare options too.
To find out more about The Skin Diary, visit http://theskindiary.com.
